Management of advanced cutaneous T-cell lymphoma: role of the dermatologist in the multidisciplinary team
Open Access
- 27 August 2015
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 173 (4) , 1081-1083
Abstract
No abstract availableKeywords
Funding Information
- Celgene
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K08 AR055986)
- Ted Schwartz Family Foundation
This publication has 22 references indexed in Scilit:
- Bacterial Toxins Fuel Disease Progression in Cutaneous T-Cell LymphomaToxins, 2013
- Pruritus in cutaneous T-cell lymphoma: A reviewJournal of the American Academy of Dermatology, 2012
- Incidence and survival patterns of cutaneous T-cell lymphomas in the United StatesLeukemia & Lymphoma, 2012
- Early CTCL diagnosis, a (miR)age no more?Blood, 2011
- Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of CancerJournal of Clinical Oncology, 2011
- Mycosis fungoides and Sézary syndrome: the burden of pruritusCommunity Oncology, 2010
- Pruritus in Cutaneous T-cell Lymphomas: Frequent, Often Severe and Difficult to TreatActa Dermato-Venereologica, 2010
- Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)Blood, 2007
- Defining early mycosis fungoidesJournal of the American Academy of Dermatology, 2005
- Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sézary syndromeBlood, 2003